For the year ending 2025-12-31, ACAD made $1,071,505K in revenue. $391,000K in net income. Net profit margin of 36.49%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 1,071,505 | 957,797 | ||
| Cost of product sales | 88,998 | 81,841 | ||
| Research and development | 328,802 | 303,249 | ||
| Selling, general and administrative | 548,894 | 488,428 | ||
| Gain on sale of non-financial asset | 0 | 146,515 | ||
| Total operating expenses | 966,694 | 727,003 | ||
| Income (loss) from operations | 104,811 | 230,794 | ||
| Interest income, net | 31,722 | 25,458 | ||
| Other income | 2,371 | 1,823 | ||
| Income (loss) before income taxes | 138,904 | 258,075 | ||
| Income tax (benefit) expense | -252,096 | 31,624 | ||
| Consolidated net income | 391,000 | 226,451 | ||
| Basic EPS | 2.32 | 1.37 | ||
| Diluted EPS | 2.3 | 1.36 | ||
| Basic Average Shares | 168,356,000 | 165,717,000 | ||
| Diluted Average Shares | 169,919,000 | 166,362,000 | ||
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)